Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Latest filing published 18 Sept 2024 for G1 Therapeutics, Inc..
Filing timeline
BuySaleTerry L. Murdock
Insider track record
Disclosed buys
0
Disclosed sells
15
Signal history
Terry L. Murdock: trading record in brief
Terry L. Murdock (senior executive) discloses dealings in G1 Therapeutics, Inc. to SEC (Form 4). Between 3 August 2018 and 18 September 2024, the trades on record add up to 29 filings.
On the market, this insider has only sold: 15 sales, €819k in total. Besides market trades, the filings include 7 share grants and 5 option exercises. 2024 to date brings no purchases and 5 sales.
Most recently, on 18 September 2024, the filings show a transaction in G1 Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Terry L. Murdock
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
17,900 sharesCommon StockSEC:0000950170-24-107789:0
2,475 shares@ US$2.507711.9% of flowCommon StockSEC:0001562180-24-005659:0
35,000 shares0Common StockSEC:0001562180-24-005607:0
8,151 shares@ US$4.788875.0% of flowCommon StockSEC:0001562180-24-004062:0
37,300 shares0Common StockSEC:0001562180-24-000322:0
1,361 shares@ US$2.45376.4% of flowCommon StockSEC:0001562180-23-005816:0
35,000 shares0Common StockSEC:0001562180-23-004099:0
17,900 shares0Common StockSEC:0001562180-23-000254:0
648 shares@ US$5.17156.8% of flowCommon StockSEC:0001562180-22-005556:0
12,000 shares0Common StockSEC:0001562180-22-000307:0
10 of 8 declarations
